MBX Biosciences, Inc.
MBX· Nasdaq
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-Q.
no prior Q4 2022 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MBX Biosciences, Inc. · CIK 1776111 · Engraved from SEC EDGAR